A logo Agilent Technologies +
Agilent Technologies
+

Agilent Technologies (A) Business News

Track Agilent Technologies in real time with a live news feed covering Agilent Technologies stock news, official press releases, company announcements, and an archive of historical Agilent Technologies news. ...more

  • Calendar
    Years
    Get instant access
    Sign up for free
    Get instant access
    Sign up for free
    Month
    Jan
    Feb
    Mar
    Apr
    May
    Jun
    Jul
    Aug
    Sep
    Oct
    Nov
    Dec
    Date
    Su
    Mo
    Tu
    We
    Th
    Fr
    Sa
    Selected Filter
    No selection

Agilent Strengthens Biopharma Growth Prospects With AI Expansion

Zacks Investment Research

2:55 PM | Thursday | Jul 9, 2026

news photo
Loading...

A enhances AI-powered lab software, automation and digital workflows to support drug discovery, biopharma research and long-term growth.

Read full article redirect
2:55 PM | Thursday | Jul 9, 2026

Agilent Strengthens Biopharma Growth Prospects With AI Expansion

Zacks Investment Research

A enhances AI-powered lab software, automation and digital workflows to support drug discovery, biopharma research and long-term growth.

Read full article arrow
News Thumbnail
2:55 PM | Thursday | Jul 9, 2026

Agilent Strengthens Biopharma Growth Prospects With AI Expansion

Zacks Investment Research

A enhances AI-powered lab software, automation and digital workflows to support drug discovery, biopharma research and long-term growth.

Read full article arrow
News Thumbnail
8:00 AM | Wednesday | Jul 8, 2026

Agilent Expands Altura Portfolio with Inert Size Exclusion and PLRP-S Columns for Biotherapeutic Analysis

Business Wire

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the latest expansion of its Altura HPLC column portfolio with the introduction of Altura size exclusion chromatography (SEC) and Altura PLRP-S columns, designed to support critical analytical workflows in biopharmaceutical development and production.The new SEC and PLRP-S columns support critical analytical workflows across a range of biotherapeutic modalities, including peptides, proteins, oligonucleotides.

Read full article arrow
News Thumbnail
11:00 AM | Tuesday | Jul 7, 2026

Alpha and Omega Semiconductor Unveils AmpStack™ Packaging: A Leap Forward in MOSFET Power Density

GuruFocus

[url="]Alpha and Omega Semiconductor Limited[/url] (AOS) (Nasdaq: AOSL), a designer, developer, and global supplier of a broad range of discrete power devices,

Read full article arrow
News Thumbnail
8:00 AM | Wednesday | Jul 1, 2026

Agilent Launches AI-Driven Analysis Module for Agilent xCELLigence RTCA eSight

Business Wire

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of Agilent xCELLigence RTCA eSight AI, a new AI-powered software module that simplifies label-free imaging analysis by reducing manual cell segmentation steps and parameter tuning and supporting more consistent results. The software upgrade enhances the unique dual-readout capabilities of the Agilent xCELLigence RTCA eSight instrument with AI-driven cell imaging analysis, enabling researchers to.

Read full article arrow
News Thumbnail
12:31 PM | Friday | Jun 26, 2026

Why Is Agilent (A) Up 0.1% Since Last Earnings Report?

Zacks Investment Research

Agilent (A) reported earnings 30 days ago. What's next for the stock?

Read full article arrow
News Thumbnail
8:06 AM | Thursday | Jun 25, 2026

Excellere Partners and GHO Capital complete sale of Biocare Medical to Agilent Technologies

GlobeNewsWire

Denver, CO and London, UK – 25 June 2026: Excellere Partners (“Excellere”), a Denver-based private equity firm specializing in partnering with entrepreneurs and management teams, and GHO Capital Partners LLP (“GHO”), a specialist investor in global healthcare, today announced the completion of the sale of Biocare Medical ("Biocare"), a global leader in immunohistochemistry (IHC), in situ hybridization (ISH) and fluorescence in situ hybridization (FISH) solutions, to Agilent Technologies, Inc. ("Agilent", NYSE:A).

Read full article arrow
News Thumbnail
8:00 AM | Thursday | Jun 25, 2026

Agilent Completes Acquisition of Biocare Medical

Business Wire

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the successful completion of its previously announced acquisition of Biocare Medical, a global leader in clinical pathology, from an investor group led by Excellere Partners and GHO Capital Partners LLP. Following the close of the transaction, Biocare is now part of Agilent's Life Sciences and Diagnostics Markets Group.“We are pleased to complete our acquisition of Biocare, which represents a natural and st.

Read full article arrow
News Thumbnail
10:30 AM | Wednesday | Jun 24, 2026

Canadian Apartment REIT: A 4.5% Dividend Yield With Ample Coverage

Seeking Alpha

Canadian Apartment Properties REIT trades at 15x AFFO and nearly 40% below NAV, offering compelling value. Q1 AFFO per share declined just 1.5% to C$0.513, with a strong 70% payout ratio and robust distribution coverage. Active buybacks and retained AFFO (~C$100 million/year) support growth initiatives and the development pipeline.

Read full article arrow
News Thumbnail
10:09 AM | Wednesday | Jun 24, 2026

Lost Money on Verra Mobility Corporation (VRRM)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky

PRNewsWire

Alert: Claims Focus on Alleged Misrepresentations About the Durability of Verra Mobility's Largest Customer Contract and the $35 Million Revenue Hole Left by Avis Budget Group's Termination NEW YORK, June 24, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP reminds purchasers of Verra Mobility Corporation (NASDAQ: VRRM) securities of a pending securities class action. THE CASE: A class action seeks to recover damages for investors who purchased VRRM securities between February 24, 2026 and May 26, 2026.

Read full article arrow
News Thumbnail
10:09 AM | Wednesday | Jun 24, 2026

Lost Money on Zoetis Inc. (ZTS)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky

PRNewsWire

Alert: Claims Focus on Alleged Misrepresentations About Weakening Veterinarian Adoption and Prescription Trends That Cost ZTS Investors $23.91 Per Share Following the Final Disclosure NEW YORK, June 24, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP reminds purchasers of Zoetis Inc. (NYSE: ZTS) securities of a pending securities class action. THE CASE: A class action seeks to recover damages for investors who purchased Zoetis securities between January 14, 2025 and May 6, 2026.

Read full article arrow
News Thumbnail